Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palomar Medical Systems was a leading researcher and manufacturer of laser and light-based systems for aesthetic and medical treatments. The company is widely recognized for pioneering high-power diode laser technology for permanent hair reduction and fractional laser technology for skin resurfacing. Their product portfolio included well-known systems such as the Icon, Vectus, and StarLux, which addressed a variety of dermatological conditions including scars, stretch marks, and vascular lesions. Palomar held numerous foundational patents in the field of energy-based medicine, particularly in the area of fractional photothermolysis. In 2013, the company was acquired by Cynosure in a deal that consolidated two of the most significant players in the aesthetic device market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Palomar Medical Systems.